Abstract
Labor was successfully induced or stimulated with intravenous Prostaglandin E2 (0.1-2.0 microgram/min) in a group of twenty-nine hypertensive gravidae at 36-41 weeks' gestation. No adverse maternal or perinatal effects of the drug were recorded.
MeSH terms
-
Female
-
Fetal Heart / drug effects
-
Fetal Monitoring
-
Humans
-
Hypertension*
-
Infant, Newborn
-
Labor, Induced*
-
Pregnancy
-
Pregnancy Complications, Cardiovascular*
-
Prostaglandins E / administration & dosage*
-
Uterine Contraction / drug effects*